Device Trial Radar · NCT06622265
WHOOP ECG Software Performance Assessment Study
Last checked: Nov 20, 2026Latest source record: Oct 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
540
Actual
Start
May 15, 2024
Primary completion
Jul 3, 2024
Study completion Jul 3, 2024
Sponsor
- Lead sponsor
- Whoop Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 2, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the performance of ECG classification algorithms and their ability to classify heart rhythms into multiple categories of rhythms and heart rates.
Conditions
- Atrial Fibrillation (AF)
Interventions
Electrocardiogram recordingDevice
ECG recording with investigational device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Specificity of the WHOOP ECG Feature for detection of sinus rhythmTime frame: 1 Day
- Sensitivity of the WHOOP ECG Feature for detection of atrial fibrillationTime frame: 1 Day
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
HOPE Research Institute
Phoenix, Arizona
Valley Clinical Trials
Covina, California
Valley Clinical Trials
Northridge, California
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.